Related Experiment Videos

Antenatal diagnosis of sphingolipid and mucopolysaccharide storage diseases

Insights

Prenatal diagnosis identified six fetuses with sphingolipid or mucopolysaccharide storage diseases. Affected fetuses lacked specific enzyme activity, but placental tissue showed partial enzyme levels.

Area of Science:

  • Medical Genetics
  • Biochemistry
  • Prenatal Diagnosis

Background:

  • Sphingolipid and mucopolysaccharide storage diseases are inherited metabolic disorders.
  • Early diagnosis is crucial for managing these severe conditions.

Purpose of the Study:

  • To evaluate the feasibility of prenatal diagnosis for sphingolipid and mucopolysaccharide storage diseases.
  • To assess enzyme activity in fetal cells and placental tissue.

Main Methods:

  • Amniocentesis was performed at 16 weeks' gestation.
  • Amniotic fluid cells were cultured and analyzed for specific enzyme deficiencies.
  • Affected fetuses were examined morphologically and biochemically post-abortion.

Main Results:

  • Out of 24 at-risk fetuses, six were diagnosed with storage diseases.
  • Diagnoses included Tay-Sachs disease (2), GM1 gangliosidosis (2), and Hurler's syndrome (1).
  • Affected fetuses showed absent specific enzyme activity, while placentas retained 5-50% of normal activity.

Conclusions:

  • Prenatal diagnosis is effective for identifying fetuses with sphingolipid and mucopolysaccharide storage diseases.
  • Placental enzyme activity does not accurately reflect fetal enzyme status in these conditions.

Related Concept Videos